Acasti Pharma reported $0 in Debt for its fiscal quarter ending in September of 2024.





Debt Change Date
Acasti Pharma USD 0 0 Sep/2024
Addus HomeCare USD 120.96M 29.68M Dec/2025
Amarin USD 0 0 Mar/2025
Cassava Sciences USD 0 0 Dec/2024
Knight Therapeutics CAD 106.24M 1.5M Sep/2025
Option Care Health USD 1.15B 1M Dec/2025
Tilray USD 640.95M 35.17M Jun/2022